UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Severe Osteoporosis in Mice Lacking Osteoclastogenesis Inhibitory Factor/Osteoprotegerin

Biochemical and biophysical research communications, 1998-06, Vol.247 (3), p.610-615

1998

Volltextzugriff (PDF)

Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis

Journal of bone and mineral metabolism, 2002-01, Vol.20 (6), p.337-344

2002

Volltextzugriff (PDF)

Characterization of Monomeric and Homodimeric Forms of Osteoclastogenesis Inhibitory Factor

Biochemical and biophysical research communications, 1998-04, Vol.245 (2), p.382-387

1998

Volltextzugriff (PDF)

Osteoclastogenesis inhibitory factor/osteoprotegerin ameliorates the decrease in both bone mineral density and bone strength in immobilized rats

Journal of bone and mineral metabolism, 2002, Vol.20 (1), p.14-20

2002

Volltextzugriff (PDF)

SNF4435C and D, Novel Immunosuppressants Produced by a Strain of Streptomyces spectabilis: III. Immunosuppressive Efficacy

The Journal of Antibiotics, 2002/01/25, Vol.55(1), pp.71-77

2002

Volltextzugriff (PDF)

Preventive effects of the deleted form of hepatocyte growth factor against various liver injuries

European journal of pharmacology, 1998-01, Vol.342 (2), p.267-279

1998

Volltextzugriff (PDF)

Effective Administration Route for the Deleted Form of Hepatocyte Growth Factor To Exert Its Pharmacological Effects

Journal of pharmaceutical sciences, 1999-01, Vol.88 (1), p.131-135

1999

Volltextzugriff (PDF)

Amelioration of Disordered Hepatic Protein Synthesis by the Deleted Form of Hepatocyte Growth Factor in Models of Liver Failure in Rats

Journal of pharmacy and pharmacology, 1996-08, Vol.48 (8), p.876-879

1996

Volltextzugriff (PDF)

Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats

Hepatology (Baltimore, Md.), 1996-09, Vol.24 (3), p.636-642

1996

Volltextzugriff (PDF)

An Antioxidative Nutrient-Rich Enteral Diet Attenuates Lethal Activity and Oxidative Stress Induced by Lipopolysaccharide in Mice

JPEN. Journal of parenteral and enteral nutrition, 2007-05, Vol.31 (3), p.181-187

2007

Volltextzugriff (PDF)

Effects of the Deleted Form of Hepatocyte Growth Factor on Serum Hyaluronate Levels in Rats with Liver Cirrhosis

Journal of Veterinary Medical Science, 1998, Vol.60(3), pp.359-360

1998

Volltextzugriff (PDF)

A deleted form of human hepatocyte growth factor stimulates hepatic lipogenesis and lipoprotein synthesis in rats

Pharmacological research, 2000-11, Vol.42 (5), p.443-452

2000

Volltextzugriff (PDF)

Reduction of monocrotaline-induced hepatic injury by deleted variant of hepatocyte growth factor (dHGF) in rats

Liver (Copenhagen), 2002-08, Vol.22 (4), p.302-307

2002

Volltextzugriff (PDF)

14.ALPHA.-Hydroxyandrost-4-ene-3,6,17-trione as a mechanical-based irreversible inhibitor of estrogen biosynthesis

Chemical & pharmaceutical bulletin, 1990, Vol.38 (10), p.2834-2837

1990

Volltextzugriff (PDF)

EFFECTS OF HYPOXIA, 2, 4-DINITROPHENOL AND OUABAIN ON TWITCH POTENTIATION ELICITED FOLLOWING CONDITIONING PULSES IN THE MOUSE PHRENIC NERVE-DIAPHRAGM PREPARATION

The Journal of Toxicological Sciences, 1987/08/25, Vol.12(3), pp.291-300

1987

Volltextzugriff (PDF)

General Pharmacological Profile of the Novel Muscarinic Receptor Agonist SNI-2011, a Drug for Xerostomia in Sjögren’s Syndrome

Arzneimittel-Forschung, 2011-12, Vol.52 (2), p.81-88

2011

Volltextzugriff (PDF)

General Pharmacological Profile of the Novel Muscarinic Receptor Agonist SNI-2011, a Drug for Xerostomia in Sjögren’s Syndrome

Arzneimittel-Forschung, 2011-12, Vol.52 (4), p.225-232

2011

Volltextzugriff (PDF)

General Pharmacological Profile of the Novel Muscarinic Receptor Agonist SNI-2011, a Drug for Xerostomia in Sjögren’s Syndrome

Arzneimittel-Forschung, 2011-12, Vol.52 (1), p.14-20

2011

Volltextzugriff (PDF)

Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis in Vitro1

Endocrinology (Philadelphia), 1998-03, Vol.139 (3), p.1329-1337

1998

Volltextzugriff (PDF)

Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis in Vitro 1

Endocrinology (Philadelphia), 1998-03, Vol.139 (3), p.1329-1337

1998

Volltextzugriff (PDF)

Central muscarinic activities of an M1-selective agonist: preferential effect on reversal of amnesia

Brain research, 1990-01, Vol.507 (1), p.172-175

1990

Volltextzugriff (PDF)

Erratum

Naunyn-Schmiedeberg's archives of pharmacology, 1986-12, Vol.334 (4), p.544-544

1986

Volltextzugriff (PDF)

Study of Solidified Enteral and Oral Nutritional Formula on Transformation and Transit in Digestive Tract-Fundamental Experiments in Rats

Jomyaku Keicho Eiyo, 2006, Vol.21(2), pp.2_115-2_125

2006

Volltextzugriff (PDF)

14α-Hydroxyandrost-4-ene-3, 6, 17-trione as a Mechanical-Based Irreversible Inhibitor of Estrogen Biosynthesis

Chemical and Pharmaceutical Bulletin, 1990/10/25, Vol.38(10), pp.2834-2837

1990

Volltextzugriff (PDF)

Effects of sulfhydryl agents on neuromuscular transmission in the presence or absence of cadmium

Naunyn-Schmiedeberg's archives of pharmacology, 1986-08, Vol.333 (4), p.450-453

1986

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(34)

Sprache

Englisch
(28)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Animals
(19)
Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Biological And Medical Sciences
(15)
Male
(15)
Medical Sciences
(12)
Rats
(12)
Mice
(11)
Pharmacology & Pharmacy
(9)
Pharmacology. Drug Treatments
(9)
Rats, Wistar
(9)
Female
(6)
Digestive System
(5)
Humans
(5)
Chemistry
(4)
Chemistry, Medicinal
(4)
Chemistry, Multidisciplinary
(4)
Hepatocyte Growth Factor - Pharmacology
(4)
Mice, Inbred Icr
(4)
Physical Sciences
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Severe Osteoporosis in Mice Lacking Osteoclastogenesis Inhibitory Factor/Osteoprotegerin

Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis

Characterization of Monomeric and Homodimeric Forms of Osteoclastogenesis Inhibitory Factor

Osteoclastogenesis inhibitory factor/osteoprotegerin ameliorates the decrease in both bone mineral density and bone strength in immobilized rats

SNF4435C and D, Novel Immunosuppressants Produced by a Strain of Streptomyces spectabilis: III. Immunosuppressive Efficacy

Preventive effects of the deleted form of hepatocyte growth factor against various liver injuries

Effective Administration Route for the Deleted Form of Hepatocyte Growth Factor To Exert Its Pharmacological Effects

Amelioration of Disordered Hepatic Protein Synthesis by the Deleted Form of Hepatocyte Growth Factor in Models of Liver Failure in Rats

Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats

An Antioxidative Nutrient-Rich Enteral Diet Attenuates Lethal Activity and Oxidative Stress Induced by Lipopolysaccharide in Mice

Effects of the Deleted Form of Hepatocyte Growth Factor on Serum Hyaluronate Levels in Rats with Liver Cirrhosis

A deleted form of human hepatocyte growth factor stimulates hepatic lipogenesis and lipoprotein synthesis in rats

Reduction of monocrotaline-induced hepatic injury by deleted variant of hepatocyte growth factor (dHGF) in rats

14.ALPHA.-Hydroxyandrost-4-ene-3,6,17-trione as a mechanical-based irreversible inhibitor of estrogen biosynthesis

EFFECTS OF HYPOXIA, 2, 4-DINITROPHENOL AND OUABAIN ON TWITCH POTENTIATION ELICITED FOLLOWING CONDITIONING PULSES IN THE MOUSE PHRENIC NERVE-DIAPHRAGM PREPARATION

General Pharmacological Profile of the Novel Muscarinic Receptor Agonist SNI-2011, a Drug for Xerostomia in Sjögren’s Syndrome

General Pharmacological Profile of the Novel Muscarinic Receptor Agonist SNI-2011, a Drug for Xerostomia in Sjögren’s Syndrome

General Pharmacological Profile of the Novel Muscarinic Receptor Agonist SNI-2011, a Drug for Xerostomia in Sjögren’s Syndrome

Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis in Vitro1

Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis in Vitro 1

Central muscarinic activities of an M1-selective agonist: preferential effect on reversal of amnesia

Erratum

Study of Solidified Enteral and Oral Nutritional Formula on Transformation and Transit in Digestive Tract-Fundamental Experiments in Rats

14α-Hydroxyandrost-4-ene-3, 6, 17-trione as a Mechanical-Based Irreversible Inhibitor of Estrogen Biosynthesis

Effects of sulfhydryl agents on neuromuscular transmission in the presence or absence of cadmium

Suchergebnisse filtern